Journal: |
CHEMICAL BIOLOGY \& DRUG DESIGN
WILEY-BLACKWELL
|
Volume: |
80
|
Abstract: |
N-Protected cysteines 4ac each with a free sulfhydryl group were prepared in 7075\% yields by treatment of l-cysteine with 1-(benzyloxycarbonyl) benzotriazole (Cbz-Bt) 1a, N-(tert-butyloxy-carbonyl)benzotriazole (Boc-Bt) 1b, and 1-(9-fluorenylmethoxy-carbonyl)benzotriazole (Fmoc-Bt) 1c, respectively. N-Protected, free sulfhydryl cysteines 4ac were then converted into the corresponding N-protected, free sulfhydryl cysteinoylbenzotriazoles 7ac (7085\%), which on treatment with diverse amino acids and dipeptides afforded the corresponding N-protected, free sulfhydryl N-terminal cysteine dipeptides 8ae and tripeptides 8fh in 7380\% yields. N-Protected, free sulfhydryl cysteine-containing dipeptides 9a,b were converted into the corresponding N-protected, free sulfhydryl dipeptidoylbenzotriazoles 10a,b (6981\%), which on treatment with amino acids, dipeptides, and a tripeptide afforded internal cysteine tripeptides 11ac, tetrapeptides 11d,e and pentapeptide 11f, each containing a N-protected, free sulfhydryl groups in 7090\% yields under mild conditions. Treatment of N-protected, free sulfhydryl cysteinoylbenzotriazole 7a with diamines 12a,b afforded directly the cysteine-containing disulfide-bridged cyclic peptides 14a,b in 50\% yields.
|
|
|